AzTrials
AzTrials

Post-Acute-Stroke RehabilitationNCT04997408

Effectiveness of a Wearable Device-based Assisted Post-stroke Rehabilitation System

A study testing Customized exercise app and In-person therapist-supervised rehabilitation in people with Post-Acute-Stroke Rehabilitation, run by Landseed Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Multidisciplinary rehabilitation facilitates functional recovery after stroke, and adherence to rehabilitation guidelines is associated with improved outcomes. We assessed the efficacy of a wearable device-assisted rehabilitation system in addition to conventional therapy compared to conventional therapy alone. Read more about this study

Who is it for?
Ages 20 to 75 years
Conditions the study is for
Post-Acute-Stroke Rehabilitation
What is being tested?
Customized exercise app and In-person therapist-supervised rehabilitation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
No sites listed yet
Study dates
Nov 2015to Apr 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Able to provide signed informed consent prior to study entry and understand the nature of this study and agree to adhere to all study protocol requirements.
  • Males and females 20-75 years of age at the time of signing the informed consent
  • Patients with first-ever acute ischemic or hemorrhagic stroke diagnosed by a neurologist or neurosurgeon within 4-12 weeks of onset,
  • A baseline modified Rankin Scale score 2-4 on enrollment,
  • A designated caregiver for each patient willing to assist the patient to be engaged in WEAR using the mobile embedded with APP.

Who cannot join

  • Planning to have further rehabilitation in other hospital and could be followed up in the participating hospital.
  • The caregiver of patients not willing to assist patients to be engaged in WEAR.

About this study

Official title: The Cost-effectiveness Analysis of a Wearable Device-based Assisted Rehabilitation System for Discharged Patient With Stroke

Multidisciplinary rehabilitation facilitates functional recovery after stroke, and adherence to rehabilitation guidelines is associated with improved outcomes. We assessed the efficacy of a wearable device-assisted rehabilitation system in addition to conventional therapy compared to conventional therapy alone.

A total of 127 eligible acute stroke inpatients were enrolled. There were 76 males (59.8%). The mean age of the participants was 57.45 years; 63 and 64 participants were randomized to the WG and CG, respectively. Both groups showed significant improvements in mRS scores at 90 days (WG: -0.68 [95% confidence interval (CI), -0.94 to -0.42]; CG: -0.56 [95% CI, -0.74 to -0.38]; P<0.0001), but only the WG had significant improvements between 30 and 90 days (-0.36; 95% CI, -0.72, -0.007; P=0.049). Both groups had significant improvements in secondary outcomes at 90 days, but there was no difference between groups.

Read the detailed description

Stroke remains the leading cause of chronic physical disability worldwide and the second most common cause of acute mortality despite great progress in acute stroke treatment during the past decades. Adherence to rehabilitation guidelines after acute stroke is associated with improved outcomes. Current stroke guidelines recommend early and continuous rehabilitation to facilitate functional recovery and a good prognosis, and more than two-thirds of stroke patients are encouraged to participate in outpatient rehabilitation programs after hospital discharge. The efficacy of rehabilitation might be enhanced by increasing the rehabilitation time using mobile communication devices (telerehabilitation). Moreover, the use of telerehabilitation should be emphasized during the era of coronavirus disease 2019 (COVID-19), when medical resources are limited and in-person contact is restricted.

During the Wearable-Assisted Rehabilitation (WEAR) for Stroke (WEAR-Stroke) trial, we aimed to investigate the efficacy of adding a 30-minute smartphone-assisted or smartwatch-assisted session to conventional in-person rehabilitation.

Several innovative interventions have been introduced beside the conventional rehabilitation because of increasing awareness of the brain's regenerative potential and advances of technology by utilizing visual feedback, transcranial magnetic stimulation and robotics. An alternative way of delivering post-stroke rehabilitation, telerehabilitation, has been proposed by information and communication technologies. The devices could detect, store and upload their physical activity recorded in the sensor-embedded mobile devices of smart watches and smartphones, with connection to the internet and get real-time feedback by the computation. The market penetration of smart mobile devices is rapidly rising in every industrial sector and professional field. The smartphone software applications (apps) are becoming increasingly popular for both health care consumers and providers. The investigators designed a customizable, sensor-driven, internet-based rehabilitation system consisting of a sensing watch, smartphone, a web server and database and users' interface for medical staff. The primary outcome was the mRS scores from baseline (D0) to 30 days (D30), from D0 to 90 days (D90), and from D30 to D90. Acute stroke therapies often use the mRS to assess the functional outcomes and activity limitations.

The secondary outcomes included changes in the following measures at D30 and D90: Barthel index (BI) score for functional recovery of activities of daily living; static and dynamic balance ability (Berg Balance Scale, BBS) scores for 14 functional tasks with varying difficulty, including sitting, standing, transferring, reaching, stepping, and turning, rated using a 5-point scale (range, 0-4) based on the performance of the subject when completing the activity; the scores of the Functional Independence Measure (FIM), which is an 18-item tool that assesses motor domains, such as self-care, continence, transfers, and locomotion, and cognitive domains, such as communication and social cognition (each item was graded from 1 to 7 according to the level of assistance required, with 1 indicating total assistance and 7 indicating complete independence); and scores of the Stream Wolf Motor Function Test (SWMFT), which assesses the ability to perform simple and complex grasp tasks and global arm movements (range, 0-5 points, with 0 indicating unable and 5 indicating normal).

The investigators successfully implement the system developed in the project into three hospitals.

Being tested
Customized exercise app, In-person therapist-supervised rehabilitation
Keywords
Rehabilitation, Stroke, Mobile devices, Telemedicine
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Customized exercise appDevice

    A Wearable Device-Based Assisted Post-Stroke Rehabilitation system

  • In-person therapist-supervised rehabilitationOther

    In-person therapist-supervised rehabilitation

Study groups in NCT04997408
Study groupRoleWhat they receive
Study ArmActive comparatorMobile device-assisted rehabilitation
Receives: Device: Customized exercise app; Other: In-person therapist-supervised rehabilitation
Control ArmActive comparatorIn-person therapist-supervised rehabilitation
Receives: Other: In-person therapist-supervised rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary outcome measure was changed in mRS, which was defined by scores of 0 to 4 on the modified Rankin scale

    The primary outcome measure was changed in mRS, which was defined by scores of 0 to 4 on the modified Rankin scale, a global seven-level measure of functioning in which scores of 0 or 1 indicate a good outcome with no or minimal neurologic symptoms, scores of 2 to 5 indicate a poor outcome with increasing degree of disability, and 6 indicates death.

    Measured: Baseline, 30 days and 90 days

Secondary outcomes (4)
  1. Change in Barthel Index (BI) at 30 days, 90 days

    Change in Barthel Index (BI) (measure performance in activities of daily living)

    Measured: Baseline, 30 days and 90 days

  2. Change in upper limb (UL) function (Stream Wolf Motor Function Test)

    Change in upper limb (UL) function (Stream Wolf Motor Function Test: assesses the ability to perform simple and complex grasp tasks and global arm movements. from 0 to 5 points. 0, unable; 5, normal.)

    Measured: Baseline, 30 days and 90 days

  3. Change in functional status (Functional Independence Measure)

    Change in functional status (Functional Independence Measure-an 18-item tool that assesses function in self-care, continence, mobility, transfers, communication, and cognition. Each item is graded from 1 to 7 according to the level of assistance required. 1, total assistance; 7, complete independence.)

    Measured: Baseline, 30 days and 90 days

  4. Change in static and dynamic balance ability (Berg balance scale)

    Change in static and dynamic balance ability (Berg balance scale 15- based on 14 functional tasks with varying difficulty, including sitting, standing, transfer, reaching, stepping, and turning. Each task was rated on a five-point scale, ranging from 0 to 4 based on the performance of the subject in completing the activity).

    Measured: Baseline, 30 days and 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2021
  2. Study startNov 2015
  3. Primary completionNov 2017
  4. Study completionApr 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective randomized study
Masking
None (open label)
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04997408
Sponsor's protocol ID
MOHW105-TDU-M-212-122008
Status last verified
May 2022
First submitted
31 Jul 2021
Last updated
17 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Ho HJ, Wu LC, Wu EH, Lee SF, Lee TH, Chiang SH, Chen CH, Chen HY, Pan SJ, Chen YW; WEAR-Stroke Study Group. Improving patient outcomes in acute and subacute stroke using a wearable device-assisted rehabilitation system: a randomized controlled trial. J Int Med Res. 2024 Oct;52(10):3000605241281425. doi: 10.1177/03000605241281425.

    PubMed 39387211

Questions about this trial

What is this clinical trial studying?

A study testing Customized exercise app and In-person therapist-supervised rehabilitation in people with Post-Acute-Stroke Rehabilitation, run by Landseed Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 May 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary outcome measure was changed in mRS, which was defined by scores of 0 to 4 on the modified Rankin scale (time frame: Baseline, 30 days and 90 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04997408, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in